Key Takeaways
- TotalEnergies (TTE) reported a strong $6.03 billion adjusted net income for Q2, driven by high commodity prices and a 4% year-on-year increase in oil and gas production.
- easyJet (EZJ) saw Q3 pretax profits plummet 70% to £85 million due to higher fuel costs and Middle East disruptions, though revenue beat estimates at £2.98 billion.
- AstraZeneca (AZN) secured European Commission approval for Etcamah, a next-generation treatment for ER+ breast cancer, following trial results showing a 56% reduction in disease progression risk.
- Centrica (CNA) outperformed expectations with an H1 adjusted operating profit of £497 million and announced an interim dividend of 2.0p per share.
- BT Group (BT.A) maintained its full-year guidance as Openreach full-fibre connections reached record levels, despite a loss of 192,000 broadband lines in Q1.
Energy and Mining: Production Gains Offset Volatility
TotalEnergies (TTE) leveraged its integrated model to deliver $13.18 billion in adjusted EBITDA for the second quarter. The company’s production reached 2.4 million barrels of oil equivalent per day (Boe/d), surpassing analyst estimates of 2.33 million. Management highlighted that organic growth from projects in Brazil and the U.S. successfully mitigated production losses in the Middle East.
Centrica (CNA) reported a resilient first half, with adjusted net income of £307 million beating the £253.5 million consensus. The company expects 2027 EBITDA to remain in line with its 2026 outlook and is progressing with life extensions for its nuclear power stations. Investors reacted positively to the earnings weighting toward the first half and the stable dividend outlook.
Anglo American (AAL) confirmed its full-year guidance in a Q2 update, reporting copper output of 173,000 tons. The mining giant is moving forward with the sale of its De Beers diamond unit and confirmed that its merger with Teck Resources remains on track. Iron ore output stood at 15.4 million metric tonnes, as the company continues its strategic portfolio simplification.
Aviation and Telecom: Navigating Structural Shifts
easyJet (EZJ) faced significant pressure as headline pretax profit fell to £85 million, down from £286 million a year ago. Despite the profit squeeze, the airline reported a revenue beat and noted that 68% of Q4 seats are already sold. The carrier is currently navigating a £5.7 billion takeover offer from Apollo as it battles rising fuel costs and a slightly lower load factor of 88.9%.
BT Group (BT.A) saw Openreach adjusted revenue hit £15.8 billion in its first quarter. While the loss of broadband lines continues, the company is on track to reach 25 million premises with full-fibre by the end of the decade. CEO Allison Kirkby emphasized that fibre now contributes to more than half of the group's broadband revenue for the first time.
Healthcare and Diplomacy: New Approvals and Regional Ties
AstraZeneca (AZN) received a major boost with the EU approval of Etcamah (camizestrant) for patients with ER+ breast cancer harboring ESR1 mutations. The drug, used in combination with CDK4/6 inhibitors, demonstrated a median progression-free survival of 16.0 months compared to 9.2 months for standard care. This marks the 11th new medicine approved out of the 20 AstraZeneca aims to launch by 2030.
On the geopolitical front, Japanese and Chinese Foreign Ministers held a brief meeting in the Philippines on the sidelines of the ASEAN summit. This encounter represents the first high-level contact between the two nations since recent tensions regarding Taiwan. Diplomats characterized the interaction as a necessary step in maintaining regional communication channels amidst ongoing maritime disputes.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.